Our findings demonstrated that SOX2-β-catenin/Beclin1/autophagy signaling axis is crucial for chemoresistance, CSCs properties, and EMT in CRC, which may help develop potential therapeutic candidates for CRC treatment. This evidence concerns the gene BECN1 and colorectal carcinoma.